Powerpack

Unlock full stockrow access for only $9.90/month and boost yourself as an investor.

  • Full quarterly history

    Every quarter and TTM period we hold, not just the last 12.

  • Analyst estimates

    Three years of forward estimates and dividend forecasts.

  • Unlimited screener

    All results, unlimited saved screens, email when a screen changes.

  • Unlimited Excel

    Full workbooks and screener exports.

  • Unlimited follows

See Powerpack
Screener Weekly Summary Pricing

Geron Corporation (GERN) vs WAVE Life Sciences Ltd. (WVE)

Geron Corporation and WAVE Life Sciences Ltd. are both Biotechnology companies. Geron Corporation and WAVE Life Sciences Ltd. are of similar size ($815.9M and $780.3M). Geron Corporation grew revenue faster over the last twelve months: 24.4% against −30.4%. Geron Corporation has the higher net margin (−33.1% vs −309.7%) and the lower return on invested capital (−89.9% vs 0.00%). Across the 18 metrics below, Geron Corporation leads on 12 and WAVE Life Sciences Ltd. on 6.

Valuation

Metric GERN WVE Biotechnology median
P/E n/m n/m 7.88
P/S 4.13 11.80 11.47
P/B 3.87 1.70 2.52
Price to free cash flow n/m n/m 21.16
EV/EBITDA n/m n/m 0.74
EV/Sales 3.59 4.71 10.73
Earnings yield (8.37%) (28.84%) (28.84%)
Free cash flow yield (13.58%) (25.05%) (23.03%)

Profitability

Metric GERN WVE Biotechnology median
Gross margin 93.51% 100.00% 65.16%
Operating margin (25.31%) (333.36%) 0.00%
Net margin (33.05%) (309.73%) 0.00%
Free cash flow margin (56.10%) (295.46%) 0.00%
Return on equity (28.28%) (68.31%) (57.72%)
Return on assets (12.59%) (49.95%) (49.22%)
Return on invested capital (89.85%) 0.00% 0.00%

Growth

Metric GERN WVE Biotechnology median
Revenue growth (TTM) 24.39% (30.42%) 5.64%
EPS growth (last fiscal year) 51.85% (72.86%) —
Revenue growth, 5-year CAGR 273.49% 16.31% 8.40%
Net income growth, 5-year CAGR 0.00% 0.00% 0.00%

Health

Metric GERN WVE Biotechnology median
Debt to equity 0.55 0.00 0.00
Current ratio 6.92 9.99 4.73
Net debt to EBITDA 3.28 2.92 0.96

Dividend

Metric GERN WVE Biotechnology median
Dividend yield — — 2.10%
Payout ratio 0.00 0.00 0.00

Size

Metric GERN WVE Biotechnology median
Market cap 815.94m 780.31m 162.10m

Compare with another peer

Any metric, up to five companies and an Excel export Powerpack